At the International AIDS Society meeting this year, a young woman from South Africa spoke. She is the first Black woman from ...

Gilead Sciences won European approval Tuesday for its new twice-annual HIV prevention shot, now called Yeytuo.

Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their viral loads to undetectable levels and then come off the medicine.

Older survivors of HIV require ethical safeguards and autonomy to feel comfortable participating in end-of-life research for a cure for HIV.

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory ...

Mothers living with Human Immunodeficiency Virus who are on Antiretroviral Therapy and with low viral load or an undetectable ...

But a cure is needed to end the pandemic. Worldwide, nearly 39 million people are living with HIV. About 77% of them are receiving treatment. There have only been three known cases of an HIV cure ...

Cure isn’t a word normally used in the context of AIDS. For most of the 35 years since HIV, the virus responsible for the disease, was first identified, doctors have viewed the notion of a cure ...

He and his colleagues will continue to monitor the man’s condition, as it is still too early to say that he has been cured of HIV. Almost 1 million people die annually from HIV-related causes.